Valturna and Atorvastatin calcium drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among people who take Valturna and Atorvastatin calcium. Common interactions include restless legs syndrome among females and drug ineffective among males.
The phase IV clinical study analyzes what interactions people who take Valturna and Atorvastatin calcium have. It is created by eHealthMe based on reports of 6 people who take Valturna and Atorvastatin calcium from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
6 people who take Valturna and Atorvastatin calcium together, and have interactions are studied.
What is Valturna?
Valturna has active ingredients of aliskiren hemifumarate; valsartan. It is often used in high blood pressure. eHealthMe is studying from 610 Valturna users for its effectiveness, alternative drugs and more.
What is Atorvastatin calcium?
Atorvastatin calcium has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 55,139 Atorvastatin calcium users for its effectiveness, alternative drugs and more.
Number of Valturna and Atorvastatin calcium reports submitted per year:
Common Valturna and Atorvastatin Calcium drug interactions by gender *:
- Restless legs syndrome
- Blood potassium decreased
- Conjunctival haemorrhage
- Drug ineffective
Common Valturna and Atorvastatin Calcium drug interactions by age *:
- Conjunctival haemorrhage
* Approximation only. Some reports may have incomplete information.
Do you take Valturna and Atorvastatin calcium?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
- Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .
Alternative drugs to, pros and cons of the 2 drugs:
Browse all drug interactions of Valturna and Atorvastatin calcium:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Atorvastatin calcium interactions:
Browse all interactions between Atorvastatin calcium and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on aliskiren hemifumarate; valsartan and atorvastatin calcium (the active ingredients of Valturna and Atorvastatin calcium, respectively), and Valturna and Atorvastatin calcium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lantus Solostar and Drug Administration Error - 6 seconds ago
- Levaquin and Meclizine drug interaction - 25 seconds ago
- Depo-Medrol and Lung Infiltration - 26 seconds ago
- Levetiracetam and Hydromorphone Hydrochloride drug interaction - 34 seconds ago
- Apresoline vs. Omeprazole - 36 seconds ago